NewsBenzingaProcessa Pharmaceuticals Files Prospectus For Offering 306.574M Common Shares On Behalf Of Selling Shareholders Processa Pharmaceuticals Files Prospectus For Offering 306.574M Common Shares On Behalf Of Selling Shareholders Benzinga 2026.10.09 20:05 (GMT+0) Open on Benzinga Other news Citigroup Maintains Neutral on Morgan Stanley, Lowers Price Target to $190 A Popular Tax-Minimizing Trade Is Juicing Wall Street’s Borrowing Binge Citigroup Maintains Buy on Bank of America, Lowers Price Target to $60 Home BancShares Q3 2026 Earnings Call Transcript Citigroup Maintains Neutral on JPMorgan Chase, Lowers Price Target to $350 RKLB Stock Alert: What to Know as Rocket Lab Announces Neutron Launch Delay
